{"denoms":[{"counts":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}],"units":"Participants"}],"groups":[{"description":"Melphalan 100mg/m2/day iv days -2 and -1\n\nMelphalan: High-dose chemotherapy regimen for conditioning treatment before autologous stem cell Transplantation. Patients will receive melphalan at a total dose of 200mg/m2, divided in two doses of 100mg/m2/day on days -2 and -1, with the ASCT at day 0.","id":"BG000","title":"Arm A (Mel)"},{"description":"Melphalan 100mg/m2/day iv days -2 and -1 Bendamustine 200mg/m2/day iv days -4 and -3\n\nMelphalan: High-dose chemotherapy regimen for conditioning treatment before autologous stem cell Transplantation. Patients will receive melphalan at a total dose of 200mg/m2, divided in two doses of 100mg/m2/day on days -2 and -1, with the ASCT at day 0.\n\nBendamustine: High-dose chemotherapy regimen for conditioning treatment before autologous stem cell Transplantation. Patients will receive bendamustine at a total dose of 400mg/m2, divided in two doses of 200mg/m2/day on days -4 and -3. Melphalan is given at a total dose of 200mg/m2, divided in two doses of 100mg/m2/day, each on days -2 and -1, with the ASCT at day 0.","id":"BG001","title":"Arm B (BenMel)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"65"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"55"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"35","upperLimit":"74","value":"62"},{"groupId":"BG001","lowerLimit":"46","upperLimit":"74","value":"65"},{"groupId":"BG002","lowerLimit":"35","upperLimit":"74","value":"63"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"44"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"41"},{"groupId":"BG002","value":"76"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"120"}],"units":"Participants"}],"title":"Switzerland"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}